glp-1 layoffs news Alarming rise in weight loss drug overdoses GLP-1 Survey: 75% of Users
Description
The reviewed papers focused on different populations: the most represented populations where those of healthy participants (14 studies) and individuals with overweight and obesity (13 studies)
Key Considerations for Patients on Weight Loss Medications (Mounjaro/Wegovy) Before Surgery Many patients are using GLP-1 medications such as Semaglutide (Wegovy) or Tirzepatide (Mounjaro) to support weight loss
If you need more individualized support, reach out to set up a free discovery call with Kristyn Hall
Conducted across 170 Veterans Affairs hospitals, the study showed a 13% reduction in major AF-related events, including hospitalizations and ablation procedures, with the greatest benefits seen in patients with severe obesity
